CXCL7



CXCL7

S1SS1D2DD2L3LL3Y4YY4A5AA5E6EE6L7LL7R8RR8C9CC9M10MM10C11CC11I12II12K13KK13T14TT14T15TT15S16SS16G17GG17I18II18H19HH19P20PP20K21KK21N22NN22I23II23Q24QQ24S25SS25L26LL26E27EE27V28VV28I29II29G30GG30K31KK31G32GG32T33TT33H34HH34C35CC35N36NN36Q37QQ37V38VV38E39EE39V40VV40I41II41A42AA42T43TT43L44LL44K45KK45D46DD46G47GG47... and 27 more residue(s)...... and 27 more residue(s)

SMILES None
InChIKey None
Sequence SDLYAELRCMCIKTTSGIHPKNIQSLEVIGKGTHCNQVEVIATLKDGRKICLDPDAPRIKKIVQKKLAGDESAD

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

CXCL7

S1SS1D2DD2L3LL3Y4YY4A5AA5E6EE6L7LL7R8RR8C9CC9M10MM10C11CC11I12II12K13KK13T14TT14T15TT15S16SS16G17GG17I18II18H19HH19P20PP20K21KK21N22NN22I23II23Q24QQ24S25SS25L26LL26E27EE27V28VV28I29II29G30GG30K31KK31G32GG32T33TT33H34HH34C35CC35N36NN36Q37QQ37V38VV38E39EE39V40VV40I41II41A42AA42T43TT43L44LL44K45KK45D46DD46G47GG47... and 27 more residue(s)...... and 27 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.